Cambridge Trust’s LumiraDx Limited Common Shares LMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-76,741
Closed -$18K 754
2023
Q3
$18K Hold
76,741
﹤0.01% 512
2023
Q2
$36.8K Sell
76,741
-17,544
-19% -$9.12K ﹤0.01% 458
2023
Q1
$43.8K Sell
94,285
-8,265
-8% -$7.92K ﹤0.01% 452
2022
Q4
$92K Sell
102,550
-45,250
-31% -$47.7K ﹤0.01% 379
2022
Q3
$151K Hold
147,800
0.01% 310
2022
Q2
$393K Buy
+147,800
New +$592K 0.02% 223

Other funds holding LMDX

Cambridge Trust's LMDX Position: Q4 2023 in Review

Cambridge Trust sold out of LumiraDx Limited Common Shares (LMDX) in Q4 2023, closing a stake of 76,741 shares — an estimated $18K sold.

Cambridge Trust first reported a position in LMDX in Q2 2022 and held it in 6 quarters. The position peaked at $393K in Q2 2022. 33 funds tracked by Wall St. Rank hold LMDX as of Q4 2023.

  • Cambridge Trust reported no remaining LumiraDx Limited Common Shares position as of Q4 2023 after selling out during the quarter.
  • Cambridge Trust sold 76,741 LumiraDx Limited Common Shares shares in Q4 2023, an estimated $18K.
  • Cambridge Trust first reported a position in LumiraDx Limited Common Shares in Q2 2022 and held it in 6 quarters.
  • Cambridge Trust's LumiraDx Limited Common Shares position peaked at $393K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q4 2023.

Based on Cambridge Trust's 13F filing for Q4 2023, filed 31 Jan 2024.